NewsRoom Articles - Page 224 of 252

ThursdayOct 12, 2017 9:30 am

ChineseInvestors.com, Inc. (CIIX) – A First Mover in CBD Skin Care

China is the second-largest global cosmetics consumer, representing $30 billion annually Savvy industry veteran recruited for vast untapped CBD skin care market 100% of cannabis skin care product market in China up for grabs It comes as little surprise that cannabidiol (CBD) likely possesses skin healing properties. Found in the marijuana plant, CBD is one of over 80 natural compounds in marijuana that have been used for centuries as natural medicines and therapeutics. Cannabis is a known anti-inflammatory, containing antioxidants and anti-aging elements, while hemp seed oil contains both omega-3 and omega-6 fatty acids. In spite of vast anecdotal evidence,…

ThursdayOct 12, 2017 9:30 am

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Oral Digestion Technology Needs No Sugar Coating

Delivery technology with application to all non-psychoactive cannabinoids Company is an enabler rather than competitor to hemp oil producers Revenue from licensing DehydraTECH oral digestion technology Thanks to Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), there’s no need for a spoonful of sugar to help the medicine go down. This innovative biotech has developed technology that masks the strong taste and odor of hemp oil products, eschewing the need for artificial sweeteners, which tend to come with their own fallout to heart and health. Lexaria’s DehydraTECH oral digestion technology is a ‘back office’ process that solves the taste and odor…

WednesdayOct 11, 2017 9:30 am

Strategic Acquisitions Add Up to Huge Revenue Growth for SinglePoint, Inc. (SING)

Company has completed three profitable strategic acquisitions during 2017 Revenue has increased 378-fold since first quarter 2017 Ideally positioned to continue acquisition strategy and further grow revenues In singling out success stories within the cannabis industry, SinglePoint, Inc. (OTC: SING) is a company that has definitely earned its place among the members of the marijuana market’s “Who’s Who.” SinglePoint has been pursuing a diversified acquisition strategy within the cannabis industry this year with great success—something discussed in detail in a recently published article (http://cnw.fm/eY3k3). SinglePoint has evolved within a short time from having its core focus on advanced payment technologies…

WednesdayOct 11, 2017 9:30 am

ChineseInvestors.com, Inc. (CIIX) Markets Hemp-Infused CBD Skin Care Line in China with Multi-Platform Strategy

CIIX’s goal is 100% growth, cost cuts and profitability in FY2018 after recording 76% YOY operating sales jump in FY2017 Valuation of CIIX “could explode with this huge potential market in China of 1.4 billion people,” according to investor relations director in SmallCapVoice interview Consilium Global Research projects CIIX sales will reach $14.8 million by FY2020 ChineseInvestors.com, Inc. (OTCQB: CIIX) is growing in numerous directions due to its diverse strategy of marketing, communications and product development both within China and to the global Chinese-speaking community. After recording YOY operating sales gains of 130% in investor relations and 57% in subscription…

WednesdayOct 11, 2017 9:30 am

India Globalization Capital (NYSE: IGC) Announces Significant Breakthrough that Could Potentially Prevent, Fight Alzheimer’s Disease

Seeks patent on new therapy for drug that employs concentrations of THC Data for drug candidate IGC-AD1 finds that it reduces buildup of ‘senior plaque’ without causing death of neurons, which can lead to memory loss IGC plans to commercialize drug as a supplement to be marketed as a medical dispensary product India Globalization Capital (NYSE MKT: IGC) recently announced that it is assembling a line of cannabis-based medical dispensary products targeting Alzheimer’s disease (http://cnw.fm/UhYF1). The company is engineering genetic cell lines which show that, at various concentrations of THC, the protein Aβ decreases as much as 40% without neuron…

TuesdayOct 10, 2017 12:53 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Bioabsorption Tech Boosting Development of CBD Products

Technology improves absorption of cannabidiol and bioactive compounds into the bloodstream It is now being used on all non-psychoactive cannabinoids and applied to edibles and health food products Patents have been awarded in the U.S. and Australia and are pending in 44 countries Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is a biosciences company that has developed delivery technologies to improve absorption of bioactive compounds. Its patent-protected technology has improved the ability of cannabinoid-products companies to deliver active ingredients to the body. With patents pending for tetrahydrocannabinol and other psychoactive cannabinoids (plus nicotine and non-steroidal anti-inflammatory drugs), the current technology…

TuesdayOct 10, 2017 9:00 am

Green Rush Offers Enticing Secondary Business Opportunities

CBDWire Editorial Coverage: Legal marijuana sales in North America hit $6.7 billion in 2016 – a 34 percent jump from the previous year, making it the fastest-growing industry on the planet, according to Arcview Market Research’s 2017 report on the marijuana market. The research firm expects those figures to soar to nearly $23 billion by 2021. Companies that provide products and services related to the broader cannabis economy enjoy huge growth potential as the industry continues its inevitable march toward full legalization, and few of them require touching a single leaf of the highly regulated plant. Companies such as SinglePoint,…

MondayOct 09, 2017 11:52 am

InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Paving the Way as Biosynthesis Promises to Revolutionize Drug Development

Forbes predicts medical marijuana sales to reach $13.3 billion by 2020 Biotech/pharma market could surpass $20 billion by 2020, per estimates from Viridian Capital Advisors InMed’s biosynthesis process uses DNA and E. coli to produce cannabinoids that are identical to the 90+ found in nature The company’s pipeline drugs, focusing on rare dermatological diseases, glaucoma and topical pain treatments, are advancing toward clinical trials There may be many companies exploring cannabinoid biosynthesis, but one in particular stands out. InMed Pharmaceuticals (CSE: IN) (OTCQB: IMLFF) has created a revolutionary process that is poised to impact the cannabinoid market. It’s just one…

MondayOct 09, 2017 9:06 am

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Scaling Up to Meet Impending Spike in Cannabis Demand

Ever at the forefront of Canada’s cannabis market, ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) was among the very first companies to obtain a cannabis production license in that country and has since been working to change the face of medical cannabis—both in Canada and globally. ABcann’s group of companies is working toward the aim of becoming the first cannabis pioneers to produce repeatable, standardized, plant-based medicines around the world. Every variable of ABcann’s cannabis growing, curing and harvesting process is computer-monitored and controlled. This high-tech indoor growing environment consistently yields a superior product that is clean, steady and repeatable—something…

FridayOct 06, 2017 1:41 pm

Algae Dynamics Corp. (ADYNF) Takes the Safe Road in Cannabis Delivery

Focused on developing remedies from cannabis oil Research programs in conjunction with Universities of Waterloo & Western Ontario Strategy to capture market share of non-smoke MMJ nutraceuticals To acquire the benefits of cannabis, there are many pathways, with some being distinctly safer than others. There are tinctures and topicals; there is dabbing; and there is vaping. There are drinks and digestibles and, of course, there is smoking. Over the last few decades, what some wits refer to as ‘puffing the magic dragon’ has emerged as the top delivery method for users of cannabis, but smoking harms nearly every organ of…

News and publishing service for CBD related companies

Contact us: 303.498.7722

ChineseInvestors.com, Inc. (CIIX) – A First Mover in CBD Skin Care

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Oral Digestion Technology Needs No Sugar Coating

Strategic Acquisitions Add Up to Huge Revenue Growth for SinglePoint, Inc. (SING)

ChineseInvestors.com, Inc. (CIIX) Markets Hemp-Infused CBD Skin Care Line in China with Multi-Platform Strategy

India Globalization Capital (NYSE: IGC) Announces Significant Breakthrough that Could Potentially Prevent, Fight Alzheimer’s Disease

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Bioabsorption Tech Boosting Development of CBD Products

Green Rush Offers Enticing Secondary Business Opportunities

InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Paving the Way as Biosynthesis Promises to Revolutionize Drug Development

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Scaling Up to Meet Impending Spike in Cannabis Demand

Algae Dynamics Corp. (ADYNF) Takes the Safe Road in Cannabis Delivery

CBDWire Currently Accepts

CBDWire

News and publishing service for CBD related companies

Contact us: 303.498.7722

CBDWire Currently Accepts

Company Search

Site Search